Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+36,024,295
Put/Call ratio
42%
SEC-reported price per share
$2.48
Number of holders
97
Value change
+$93,728,957
Number of buys
54
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
138,752,791

Security key

00461U105

Report period

Q4 2024

Institutions

97

Top holders

10

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BML Capital Management, LLC
Disclosed value leader
BML Capital Management, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F Lead comparable stake: 10% Showing 1-6 of 15 holder rows.

Quick read

BML Capital Management, LLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BML Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
BML Capital Management, LLC 10%
VANGUARD GROUP INC 3.4%
D. E. Shaw & Co., Inc. 2.4%
MILLENNIUM MANAGEMENT LLC 2.2%
Rock Springs Capital Management LP 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BML Capital Management, LLC
13F
Company
13F
10%
$16,387,500
14,250,000 shares
30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
3.4%
$5,388,323
4,685,498 shares
30 Sep 2024
D. E. Shaw & Co., Inc.
13F
Company
13F
2.4%
$3,877,627
3,371,849 shares
30 Sep 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
2.2%
$3,456,438
3,005,598 shares
30 Sep 2024
Rock Springs Capital Management LP
13F
Company
13F
2%
$3,166,519
2,753,495 shares
30 Sep 2024
Stonepine Capital Management, LLC
13F
Company
13F
1.8%
$2,827,704
2,458,873 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
97
Shares
87,478,919
Rows available
97
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2025 Across Filers

Q3 2025 holders
103
Q4 2024 holders
97
Holder diff
-6
Investor Q3 2025 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2025 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .